As the TMPRSS2:ERG gene fusion was detected in one out of two Gleason 6 cultures tested, and is associated with lethal prostate cancer [24], further study of larger samples of prostate cancer stem cells from different classes of therapy-resistant and Gleason 6 tumors is warranted. The gene discussed is TMPRSS2; the disease is prostate carcinoma.